Towards a better risk stratification for sudden cardiac death in patients with structural heart disease

Area of Science:

• Cardiology
• Medical Devices
• Electrophysiology

Background:

• Implantable cardioverter defibrillators (ICDs) are crucial for preventing sudden cardiac death (SCD) caused by ventricular arrhythmias (VA).
• Existing guidelines for ICD implantation focus on primary and secondary prevention of SCD.
• A significant number of patients receiving ICDs for primary prevention do not experience life-threatening ventricular arrhythmias.

Purpose of the Study:

• To review current risk stratification markers for identifying patients who would benefit from ICD therapy.
• To discuss the efficacy, cost-effectiveness, and complication rates associated with ICD implantation.
• To highlight the potential role of various risk markers in optimizing patient selection for ICDs.

Main Methods:

• Literature review of widely accepted and emerging risk stratification markers for ventricular arrhythmias.
• Analysis of the clinical utility and prognostic value of these risk markers.
• Discussion of the implications for patient selection in primary and secondary ICD prophylaxis.

Main Results:

• Most patients receiving ICDs for primary prevention do not experience events requiring device therapy.
• Improved risk stratification is essential to enhance the efficacy and cost-effectiveness of ICD therapy.
• Several risk markers show promise in identifying patients at higher risk for life-threatening ventricular arrhythmias.

Conclusions:

• Current patient selection for ICDs may lead to overtreatment, necessitating better risk stratification.
• Identifying appropriate candidates for ICDs can improve patient outcomes and reduce healthcare costs.
• Further research into risk markers is crucial for optimizing the use of ICDs in preventing sudden cardiac death.